Technical Analysis for VECT - VectivBio Holding AG

Grade Last Price % Change Price Change
F 9.16 2.92% 0.26
VECT closed up 2.92 percent on Wednesday, July 28, 2021, on 22 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A Down Down
Historical VECT trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 2.92%
New 52 Week Low Weakness 2.92%
Lower Bollinger Band Touch Weakness 2.92%
Oversold Stochastic Weakness 2.92%
New 52 Week Low Weakness -3.88%
Wide Bands Range Expansion -3.88%
Oversold Stochastic Weakness -3.88%
Older End-of-Day Signals for VECT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 7 days ago
Up 5% 7 days ago
Up 3% 7 days ago
Up 2% 7 days ago
Up 1% 7 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for rare conditions. It develops Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as for SBS-IF in patients with colon-in-continuity anatomy. The company was incorporated in 2019 and is headquartered in Basel, Switzerland.
Classification

Sector: Other
Industry: Other
Keywords: Clinical Medicine Gastroenterology Glucagon Like Peptide 1 Biomolecules Short Bowel Syndrome Glucagon Glucagon Like Peptide 2

Is VECT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.6999
52 Week Low 8.75
Average Volume 19,920
200-Day Moving Average 0.00
50-Day Moving Average 13.09
20-Day Moving Average 10.27
10-Day Moving Average 9.78
Average True Range 0.73
ADX 52.68
+DI 7.62
-DI 30.58
Chandelier Exit (Long, 3 ATRs) 10.67
Chandelier Exit (Short, 3 ATRs) 10.94
Upper Bollinger Bands 11.70
Lower Bollinger Band 8.83
Percent B (%b) 0.11
BandWidth 27.95
MACD Line -1.11
MACD Signal Line -1.14
MACD Histogram 0.0241
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.85
Resistance 3 (R3) 9.79 9.50 9.74
Resistance 2 (R2) 9.50 9.32 9.53 9.70
Resistance 1 (R1) 9.33 9.22 9.42 9.39 9.66
Pivot Point 9.04 9.04 9.08 9.07 9.04
Support 1 (S1) 8.87 8.86 8.96 8.93 8.66
Support 2 (S2) 8.58 8.76 8.61 8.62
Support 3 (S3) 8.41 8.58 8.59
Support 4 (S4) 8.47